Kala Pharmaceuticals Reports Third Quarter 2019 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/8/2026

1. LEVI
2. APLD
3. STZ
4. SPY
5. RMR
6. DVN
7. CRGY
8. ZETA
9. ARGX
10. GOOGL

Go back to Kala Pharmaceuticals Reports Third Quarter 2019 Financial Results

Kala Pharmaceuticals (KALA) Misses Q3 EPS by 1c

November 7, 2019 7:23 AM EST

Kala Pharmaceuticals (NASDAQ: KALA) reported Q3 EPS of ($0.68), $0.01 worse than the analyst estimate of ($0.67). Revenue for the quarter came in at $1.45 million versus the consensus estimate of $3.64 million.

INVELTYS demonstrated growing demand in the third quarter, with positive feedback from physicians and a... More